within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A10B_BloodGlucoseLoweringDrugsExclInsulins.A10BJ07_Beinaglutide;

model Beinaglutide
  extends Pharmacolibrary.Drugs.ATC.A.A10BJ07;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>A10BJ07</td></tr><td>route:</td><td>subcutaneous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Beinaglutide is a recombinant human glucagon-like peptide-1 (GLP-1) receptor agonist indicated for the management of type 2 diabetes mellitus. It mimics endogenous GLP-1 to enhance glucose-dependent insulin secretion, suppress glucagon secretion, delay gastric emptying, and promote satiety. Approved in China for type 2 diabetes, not approved in US or EU.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters based on class data and limited public sources; beinaglutide is typically studied in healthy or type 2 diabetic adult populations after subcutaneous administration.</p><h4>References</h4><ol><li><p>Lin, P, et al., &amp; Cao, Y (2024). Pharmacokinetics and safety profiles of beinaglutide injection, a recombinant human GLP-1, in adults with overweight/obesity: results from a phase I clinical trial. <i>Frontiers in pharmacology</i> 15 1433587–None. DOI:<a href=&quot;https://doi.org/10.3389/fphar.2024.1433587&quot;>10.3389/fphar.2024.1433587</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/39239660/&quot;>https://pubmed.ncbi.nlm.nih.gov/39239660</a></p></li><li><p>Young, MA, et al., &amp; Reinhardt, RR (2014). Clinical pharmacology of albiglutide, a GLP-1 receptor agonist. <i>Postgraduate medicine</i> 126(7) 84–97. DOI:<a href=&quot;https://doi.org/10.3810/pgm.2014.11.2836&quot;>10.3810/pgm.2014.11.2836</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/25387217/&quot;>https://pubmed.ncbi.nlm.nih.gov/25387217</a></p></li><li><p>Galloway, JA, &amp; Chance, RE (1994). Improving insulin therapy: achievements and challenges. <i>Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme</i> 26(12) 591–598. DOI:<a href=&quot;https://doi.org/10.1055/s-2007-1001766&quot;>10.1055/s-2007-1001766</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7705765/&quot;>https://pubmed.ncbi.nlm.nih.gov/7705765</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Beinaglutide;
